Back
ProPhase Labs Vs. OncoCyte Industry Stock Comparison
Sell
36
PRPH
ProPhase Labs
Last Price:
2.00
Seasonality Move:
22.84%
Sell
43
OCX
OncoCyte
Last Price:
2.79
Seasonality Move:
66.51%
Sell
36
ProPhase Labs (PRPH)
is a Sell
Is ProPhase Labs a Buy, Sell or Hold?
- The current ProPhase Labs [PRPH] share price is $2.08. The Score for PRPH is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- PRPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
OncoCyte (OCX)
is a Sell
Is OncoCyte a Buy, Sell or Hold?
- The current OncoCyte [OCX] share price is $2.92. The Score for OCX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- OCX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PRPH Stock Price Chart
What is ProPhase Labs's stock price today?
-
The ProPhase Labs share price today is $2.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing selling pressure, which indicates risk of future bearish movement.
OCX Stock Price Chart
PRPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 37.59 | Sell |
| Chaikin Money Flow: | -20388 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.23 - 2.43) | Sell |
| Bollinger Bands (100): | (2.2 - 3.54) | Sell |
OCX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 40.64 | Sell |
| Chaikin Money Flow: | 5897 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.97 - 3.11) | Sell |
| Bollinger Bands (100): | (2.9 - 3.2) | Sell |
PRPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.26 | Sell |
| 20-day SMA: | 2.32 | Sell |
| 50-day SMA: | 2.41 | Sell |
| 200-day SMA: | 4.07 | Sell |
| 8-day EMA: | 2.23 | Sell |
| 20-day EMA: | 2.3 | Sell |
| 50-day EMA: | 2.48 | Sell |
| 200-day EMA: | 3.74 | Sell |
OCX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.01 | Sell |
| 20-day SMA: | 3.06 | Sell |
| 50-day SMA: | 3.06 | Sell |
| 200-day SMA: | 2.96 | Sell |
| 8-day EMA: | 2.99 | Sell |
| 20-day EMA: | 3.03 | Sell |
| 50-day EMA: | 3.04 | Sell |
| 200-day EMA: | 3.26 | Sell |
ProPhase Labs Earnings Growth & PRPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and an increase next year of $0.32 per share.
OncoCyte Earnings Growth & OCX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.
ProPhase Labs Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
OncoCyte Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||